NCT01351142
Completed
Not Applicable
Cytokines and Cognitive Decline in Alzheimer's Disease
ConditionsAlzheimer's Disease
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Alzheimer's Disease
- Sponsor
- Poitiers University Hospital
- Enrollment
- 133
- Locations
- 10
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
Amyloid plaques and neurofibrillary tangles are the 2 well-known etiopathological hallmarks of Alzheimer's disease (AD). Beside these 2 lesions, inflammation response is described in the brain of patients with AD.
The main objective of our study is to analyse the correlation between the value of plasma cytokines (interleukin 1, 6, TNFα and chemochine Rantes) and the rapidity of the cognitive decline in AD over a 2-year follow-up.
Secondary objectives include:
- the predictive value of the cytokines on the cognitive decline after 6 months and one year of follow-up., of the patients include 150 patients with AD (MMSE: 16-25)
- correlation between plasma cytokines levels and expression of the protein kinase PKR (involved in death cell) in blood mononuclear cells.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Alzheimer's disease (AD)patients
- •MMSE score: 16-25
- •Written informed consent
Exclusion Criteria
- •AD patients with specific treatment for AD before inclusion MMSE score under 16 or over 25 at inclusion
- •patients with anti-inflammatory drugs (non steroids or corticosteroids) or immunosuppressive agents
- •Patients with acute disease (infectious disease, rheumatologic disease) or chronic disease (malignancy, infectious, rheumatologic disease) that could interact with plasma cytokines level
- •Patients with a life threatening disease
Outcomes
Primary Outcomes
Not specified
Study Sites (10)
Loading locations...
Similar Trials
Unknown
Not Applicable
Innovative Biomarkers in Alzheimer's Disease and Frontotemporal Dementia (FTD): Preventative and PersonalizedAlzheimer's DiseaseNCT01403519Rambam Health Care Campus70
Recruiting
Phase 2
The Influence of Vascular Burden, Amyloid Plaque and Tau Protein in Patients With Vascular Cognitive Impairment and Dementia With TauopathyVascular Cognitive Impairment, Alzheimer's Disease, Fronto-temporal DementiaNCT04309253Chang Gung Memorial Hospital220
Recruiting
Early Phase 1
Glutathione, Brain Metabolism and Inflammation in Alzheimer's DiseaseAlzheimer DiseaseNCT04740580Baylor College of Medicine52
Recruiting
Not Applicable
Tanycytes in Alzheimer's Disease and Frontotemporal DementiaAlzheimer DiseaseFrontotemporal DementiaNCT05288842University Hospital, Lille102
Completed
Early Phase 1
Neuroinflammation and Cognitive Decline in Alzheimer DiseaseAlzheimer DiseaseNCT02377206University Hospital, Tours24